Datasets:
sovai
/
lobbying_data

Dataset card Data Studio Files
xet
Community
ticker
stringlengths
1
10
date
timestamp[ns]
client
stringlengths
1
80
client_description
stringlengths
2
114
⌀
spend
float64
0
25.9M
transaction_type
stringclasses
7 values
filing_type
stringclasses
7 values
lobby_description
listlengths
0
34
issue_codes
listlengths
1
34
⌀
government_entity_details
listlengths
1
725
⌀
quarter
stringclasses
66 values
effective_date
stringlengths
10
10
termination_date
stringlengths
10
10
⌀
client_state
stringclasses
56 values
client_country
stringclasses
40 values
client_id
int64
12
10M
government_lobby
float64
0
1
⌀
performing_own_lobbying
float64
0
1
⌀
registrant_dt_updated
stringlengths
32
32
registrant_name
stringlengths
3
99
registrant_address
stringlengths
32
87
registrant_id
int64
33
401M
registrant_description
stringlengths
2
103
⌀
registrant_contact_name
stringlengths
0
34
registrant_house_registrant_id
float64
12.7k
401M
⌀
registrant_contact_telephone
stringlengths
0
16
lobbyist_full_names
listlengths
1
272
⌀
lobbyist_ids
listlengths
1
272
⌀
previous_goverment_positions
listlengths
1
272
⌀
lobbyist_new_statuses
listlengths
1
272
⌀
client_url
stringlengths
44
45
registrant_url
stringlengths
45
52
filing_url
stringlengths
88
88
filing_id
stringlengths
36
36
unique_id
stringlengths
46
53
match
stringlengths
1
80
date_time
timestamp[ns]
YNCHF
2013-04-22T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152).", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Issues related to the development of new antibiotics. Issues related to drug safety." ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q1
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY" ]
[ 47178, 26450, 41354, 47178, 26450, 41354 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/e8ac141b-8ab1-4b0e-b77a-174c621a88ed/print/
e8ac141b-8ab1-4b0e-b77a-174c621a88ed
e8ac141b-8ab1-4b0e-b77a-174c621a88ed_20744_127151
astellas pharma us, inc.
2013-04-22T18:56:51
YNCHF
2013-07-09T00:00:00
astellas pharma us, inc.
Biotechnology pharmaceutical product discovery and development.
7,500
lobbying_income
service_provided
[ "General health care coverage and reimbursement; issues related to infectious disease drug development, procurement and regulation." ]
[ "HCR - Health Issues" ]
[ "136 - Centers For Medicare and Medicaid Services (CMS)", "135 - Food & Drug Administration (FDA)", "34 - Health & Human Services, Dept of (HHS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q2
2013-01-01
null
IL
US
202
0
0
2024-01-19T13:20:04.069302-05:00
EAST END GROUP, LLC
1000 Wisconsin Ave., NW, Suite 200, Wasington, DC, 20007, US
400,646,949
Consulting and government affairs.
KELLY CHILDRESS
400,646,949
+1 202-688-1814
[ "BARRETT THORNHILL" ]
[ 52414 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/193827/
https://lda.senate.gov/api/v1/registrants/400646949/
https://lda.senate.gov/filings/public/filing/41469706-8b44-4c26-810d-62b33c1d3a40/print/
41469706-8b44-4c26-810d-62b33c1d3a40
41469706-8b44-4c26-810d-62b33c1d3a40_400646949_193827
astellas pharma us, inc.
2013-07-09T13:20:54
YNCHF
2013-07-18T00:00:00
astellas pharma us
Pharmaceutical company
75,000
lobbying_income
service_provided
[ "General Health Issues" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2012-Q1
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG", "TAMAR THOMPSON" ]
[ 42442, 51434, 53650, 51143 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/0388f94b-318e-47ba-8198-42745d561828/print/
0388f94b-318e-47ba-8198-42745d561828
0388f94b-318e-47ba-8198-42745d561828_46038_153900
astellas pharma us
2013-07-18T16:22:47
YNCHF
2013-07-19T00:00:00
astellas pharma us, inc.
null
50,000
lobbying_income
service_provided
[ "Issues relating to the implementation of the Affordable Health Care Act; S. 957, Drug Supply Chain Security Act; H. R. 1919, Safeguarding America's Pharmaceuticals Act of 2012; Issues relating to oncology; Issues relating to cardiac imaging; Issues relating to health and science education." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q2
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ", "ABBY MATOUSEK" ]
[ 31268, 55007 ]
[ null, null ]
[ false, true ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/42b7c621-6aa5-467b-b484-a7eab3664d9f/print/
42b7c621-6aa5-467b-b484-a7eab3664d9f
42b7c621-6aa5-467b-b484-a7eab3664d9f_25603_133380
astellas pharma us, inc.
2013-07-19T13:23:31
YNCHF
2013-07-22T00:00:00
astellas pharma us
Pharmaceutical company
25,000
lobbying_income
service_provided
[ "General Healthcare Issues" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q2
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (Health Aide, Sen Lamar Alexander)" ]
[ 42442, 51434, 53650 ]
[ null, null, "Health Aide, Sen Lamar Alexander" ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/7020b611-3c7a-4912-8907-b5f97a5654c7/print/
7020b611-3c7a-4912-8907-b5f97a5654c7
7020b611-3c7a-4912-8907-b5f97a5654c7_46038_153900
astellas pharma us
2013-07-22T20:08:27
YNCHF
2013-07-22T00:00:00
astellas pharma us, inc.
null
310,000
a
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q2
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "MARGARET LONG", "MARY LACEY REUTHER", "MARGARET LONG" ]
[ 54800, 58839, 54800, 58839 ]
[ null, null, null, null ]
[ false, true, false, true ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/c4a5ebae-4e24-48e6-9efa-83b20b5d954d/print/
c4a5ebae-4e24-48e6-9efa-83b20b5d954d
c4a5ebae-4e24-48e6-9efa-83b20b5d954d_40032268_188248
astellas pharma us, inc.
2013-07-22T17:16:19
YNCHF
2013-07-22T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Issues related to the development of new antibiotics. Issues related to drug safety." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q2
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY" ]
[ 47178, 26450, 41354 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/0f40925d-ef18-44e4-b6dd-249e20ba8778/print/
0f40925d-ef18-44e4-b6dd-249e20ba8778
0f40925d-ef18-44e4-b6dd-249e20ba8778_20744_127151
astellas pharma us, inc.
2013-07-22T17:56:38
YNCHF
2013-07-22T00:00:00
astellas pharma us, inc.
pharmaceutical company
30,000
lobbying_income
service_provided
[ "Issues involving:?The Federal, Food, Drug and Cosmetic Act?The Prescription Drug User Fee Act (PDUFA)?Patient Protection and Affordable Care Act?The Food and Drug Administration Safety and Innovation Act (FDASIA)", "General reimbursement issues" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q2
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "RICHARD CHARLES WHITE", "STEVEN E IRIZARRY", "STEVEN E IRIZARRY", "RICHARD CHARLES WHITE", "VINCENT A. ROBERTI, SR." ]
[ 54777, 56477, 56477, 54777, 64580 ]
[ null, null, null, null, null ]
[ false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/0c729914-e705-4cba-8714-bf8507926b0b/print/
0c729914-e705-4cba-8714-bf8507926b0b
0c729914-e705-4cba-8714-bf8507926b0b_400762305_195037
astellas pharma us, inc.
2013-07-23T01:42:10
YNCHF
2013-10-03T00:00:00
astellas pharma us, inc.
Biotechnology pharmaceutical product discovery and development.
0
lobbying_income
service_provided
[ "General health care coverage and reimbursement; issues related to infectious disease drug development, procurement and regulation." ]
[ "HCR - Health Issues" ]
[ "136 - Centers For Medicare and Medicaid Services (CMS)", "135 - Food & Drug Administration (FDA)", "34 - Health & Human Services, Dept of (HHS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q3
2013-01-01
null
IL
US
202
0
0
2024-01-19T13:20:04.069302-05:00
EAST END GROUP, LLC
1000 Wisconsin Ave., NW, Suite 200, Wasington, DC, 20007, US
400,646,949
Consulting and government affairs.
KELLY CHILDRESS
400,646,949
+1 202-688-1814
[ "BARRETT THORNHILL" ]
[ 52414 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/193827/
https://lda.senate.gov/api/v1/registrants/400646949/
https://lda.senate.gov/filings/public/filing/55dc539b-ef5c-4b7c-9316-2ca5410a826b/print/
55dc539b-ef5c-4b7c-9316-2ca5410a826b
55dc539b-ef5c-4b7c-9316-2ca5410a826b_400646949_193827
astellas pharma us, inc.
2013-10-03T13:56:06
YNCHF
2013-10-03T00:00:00
astellas pharma us, inc.
Biotechnology pharmaceutical product discovery and development.
7,500
lobbying_income
modify_termination
[ "General health care coverage and reimbursement; issues related to infectious disease drug development, procurement and regulation." ]
[ "HCR - Health Issues" ]
[ "136 - Centers For Medicare and Medicaid Services (CMS)", "135 - Food & Drug Administration (FDA)", "34 - Health & Human Services, Dept of (HHS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q3
2013-01-01
2013-09-01
IL
US
202
0
0
2024-01-19T13:20:04.069302-05:00
EAST END GROUP, LLC
1000 Wisconsin Ave., NW, Suite 200, Wasington, DC, 20007, US
400,646,949
Consulting and government affairs.
KELLY CHILDRESS
400,646,949
+1 202-688-1814
[ "BARRETT THORNHILL" ]
[ 52414 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/193827/
https://lda.senate.gov/api/v1/registrants/400646949/
https://lda.senate.gov/filings/public/filing/6020a612-88a2-4303-a383-474aaf58ad2f/print/
6020a612-88a2-4303-a383-474aaf58ad2f
6020a612-88a2-4303-a383-474aaf58ad2f_400646949_193827
astellas pharma us, inc.
2013-10-03T20:16:00
YNCHF
2013-10-17T00:00:00
astellas pharma us, inc.
null
50,000
lobbying_income
service_provided
[ "Issues relating to the implementation of the Affordable Health Care Act; H.R. 3204, Drug Quality and Security Act; Issues relating to oncology; Issues relating to 2014 Hospital Outpatient Prospective Payment System." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q3
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ", "ABBY MATOUSEK" ]
[ 31268, 55007 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/6a07e26f-4307-471e-b122-8a905e16879e/print/
6a07e26f-4307-471e-b122-8a905e16879e
6a07e26f-4307-471e-b122-8a905e16879e_25603_133380
astellas pharma us, inc.
2013-10-17T16:59:50
YNCHF
2013-10-21T00:00:00
astellas pharma us
Pharmaceutical company
25,000
lobbying_income
service_provided
[ "General Healthcare and Pharmaceutical Issues" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q3
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (Health Aide, Senator Lamar Alexander)" ]
[ 42442, 51434, 53650 ]
[ null, null, "Health Aide, Senator Lamar Alexander" ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/da900581-01cd-4212-9290-a4d3357fd4a9/print/
da900581-01cd-4212-9290-a4d3357fd4a9
da900581-01cd-4212-9290-a4d3357fd4a9_46038_153900
astellas pharma us
2013-10-21T20:16:50
YNCHF
2013-10-21T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Issues related to the development of new antibiotics. Issues related to drug safety." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q3
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY" ]
[ 47178, 26450, 41354 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/ce767c63-f5f1-4837-8588-2e5bbf807c17/print/
ce767c63-f5f1-4837-8588-2e5bbf807c17
ce767c63-f5f1-4837-8588-2e5bbf807c17_20744_127151
astellas pharma us, inc.
2013-10-21T18:09:27
YNCHF
2013-10-21T00:00:00
astellas pharma us, inc.
pharmaceutical company
30,000
lobbying_income
service_provided
[ "General reimbursement issues", "Issues involving:?The Federal, Food, Drug and Cosmetic Act\nPatient Protection and Affordable Care Act\nThe Food and Drug Administration Safety and Innovation Act (FDASIA)" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q3
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "STEVEN E IRIZARRY", "RICHARD CHARLES WHITE", "VINCENT A. ROBERTI, SR.", "ARI MITTLEMAN", "STEVEN E IRIZARRY", "RICHARD CHARLES WHITE", "VINCENT A. ROBERTI, SR.", "ARI MITTLEMAN" ]
[ 56477, 54777, 64580, 58926, 56477, 54777, 64580, 58926 ]
[ null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/72ea4b62-f41a-4d89-8a1b-4886bbe33ee0/print/
72ea4b62-f41a-4d89-8a1b-4886bbe33ee0
72ea4b62-f41a-4d89-8a1b-4886bbe33ee0_400762305_195037
astellas pharma us, inc.
2013-10-21T18:56:12
YNCHF
2013-10-21T00:00:00
astellas pharma us, inc.
null
500,000
a
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152).\nIssues related to the Medicare hospital outpatient proposed rule (no specific bills).", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)\nCancer Drug Coverage Parity Act (H.R. 1801, no specific Senate bill)." ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q3
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "MARGARET LONG", "MARY LACEY REUTHER", "MARGARET LONG" ]
[ 54800, 58839, 54800, 58839 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/922ce8e6-4458-4745-8bf3-056ab7745b4e/print/
922ce8e6-4458-4745-8bf3-056ab7745b4e
922ce8e6-4458-4745-8bf3-056ab7745b4e_40032268_188248
astellas pharma us, inc.
2013-10-21T23:25:20
YNCHF
2013-10-23T00:00:00
astellas pharma us, inc.
Client is a pharmaceutical company.
5,000
lobbying_income
service_provided
[ "Development of policies to advance the antimicrobial research and development environment." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q3
2013-09-16
null
IL
US
393
0
0
2024-01-31T11:02:48.049026-05:00
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
286,096
Consulting
NATE GASPAR
36,969
+1 434-989-7548
[ "BARRETT THORNHILL" ]
[ 59333 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/176451/
https://lda.senate.gov/api/v1/registrants/286096/
https://lda.senate.gov/filings/public/filing/e7921157-c38a-46a7-81fe-5b44a7e9bbdc/print/
e7921157-c38a-46a7-81fe-5b44a7e9bbdc
e7921157-c38a-46a7-81fe-5b44a7e9bbdc_286096_176451
astellas pharma us, inc.
2013-10-23T17:32:51
YNCHF
2014-01-14T00:00:00
astellas pharma us
Pharmaceutical company
25,000
lobbying_income
service_provided
[ "GENERAL HEALTH CARE ISSUES, ISSUES RELATED TO FDA, PHARMACEUTICALS" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q4
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (HEALTH AIDE, SEN. LAMAR ALEXANDER)" ]
[ 42442, 51434, 53650 ]
[ null, null, "HEALTH AIDE, SEN. LAMAR ALEXANDER" ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/34287702-2689-4c5e-a482-46c7d33b18d1/print/
34287702-2689-4c5e-a482-46c7d33b18d1
34287702-2689-4c5e-a482-46c7d33b18d1_46038_153900
astellas pharma us
2014-01-14T21:39:48
YNCHF
2014-01-21T00:00:00
astellas pharma us, inc.
null
500,000
a
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)\nCancer Drug Coverage Parity Act (H.R. 1801, no specific Senate bill).", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152).\nIssues related to the Medicare hospital outpatient proposed rule (no specific bills)." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q4
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK" ]
[ 54800, 59772, 54800, 59772 ]
[ null, null, null, null ]
[ false, true, false, true ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/d7d75a60-6e9c-4281-9514-4ee77a874c05/print/
d7d75a60-6e9c-4281-9514-4ee77a874c05
d7d75a60-6e9c-4281-9514-4ee77a874c05_40032268_188248
astellas pharma us, inc.
2014-01-21T14:24:41
YNCHF
2014-01-21T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Issues related to the development of new antibiotics. Issues related to drug safety. Issues related to CMS Outpatient Prospective Payment System (OPPS) rule.", "H.J. Res. 59, Continuing Appropriations Resolution, 2014 and budget deal. The sequester as it relates to FDA user fees.", "Track and trace drug verification. H.R. 3204, Drug Quality and Security Act. S. 959, Pharmaceutical Quality, Security, and\nAccountability Act. S. 957, Drug Supply Chain Security Act." ]
[ "HCR - Health Issues", "BUD - Budget/Appropriations", "PHA - Pharmacy" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q4
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY" ]
[ 47178, 26450, 41354, 47178, 26450, 41354, 47178, 26450, 41354 ]
[ null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/af2a2fab-a174-4bc7-9d3f-16497568d330/print/
af2a2fab-a174-4bc7-9d3f-16497568d330
af2a2fab-a174-4bc7-9d3f-16497568d330_20744_127151
astellas pharma us, inc.
2014-01-21T15:05:29
YNCHF
2014-01-21T00:00:00
astellas pharma us, inc.
null
50,000
lobbying_income
service_provided
[ "Issues relating to the implementation of the Affordable Care Act; issues relating to the implementation of the Generating Antibiotic Incentives Now (GAIN) Act; H.R. 1801, Cancer Drug Coverage Parity Act; issues relating to the 2014 Hospital Outpatient Prospective Payment System." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q4
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ", "ABBY MATOUSEK" ]
[ 31268, 55007 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/66809de9-05d1-4021-a885-a86ed91578e9/print/
66809de9-05d1-4021-a885-a86ed91578e9
66809de9-05d1-4021-a885-a86ed91578e9_25603_133380
astellas pharma us, inc.
2014-01-21T16:16:23
YNCHF
2014-01-21T00:00:00
astellas pharma us, inc.
Client is a pharmaceutical company.
0
lobbying_income
service_provided
[ "Development of policies to advance the antimicrobial research and development environment." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q4
2013-09-16
null
IL
US
393
0
0
2024-01-31T11:02:48.049026-05:00
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
286,096
Consulting
NATE GASPAR
36,969
+1 434-989-7548
[ "BARRETT THORNHILL", "JOHN MCMANUS", "SHAWN BISHOP" ]
[ 59333, 9573, 59510 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/176451/
https://lda.senate.gov/api/v1/registrants/286096/
https://lda.senate.gov/filings/public/filing/c29f43cf-d27e-439c-ae41-f667ba88f4df/print/
c29f43cf-d27e-439c-ae41-f667ba88f4df
c29f43cf-d27e-439c-ae41-f667ba88f4df_286096_176451
astellas pharma us, inc.
2014-01-21T18:20:10
YNCHF
2014-01-22T00:00:00
astellas pharma us, inc.
pharmaceutical company
30,000
lobbying_income
service_provided
[ "General reimbursement issues", "Issues involving:?The Federal, Food, Drug and Cosmetic Act\nPatient Protection and Affordable Care Act\nThe Food and Drug Administration Safety and Innovation Act (FDASIA)" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q4
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "STEVEN E IRIZARRY", "RICHARD CHARLES WHITE", "VINCENT A. ROBERTI, SR.", "ARI MITTLEMAN", "STEVEN E IRIZARRY", "RICHARD CHARLES WHITE", "VINCENT A. ROBERTI, SR.", "ARI MITTLEMAN" ]
[ 56477, 54777, 64580, 58926, 56477, 54777, 64580, 58926 ]
[ null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/4b08a374-011b-44af-afac-663d287c6057/print/
4b08a374-011b-44af-afac-663d287c6057
4b08a374-011b-44af-afac-663d287c6057_400762305_195037
astellas pharma us, inc.
2014-01-22T01:59:20
YNCHF
2014-04-17T00:00:00
astellas pharma us, inc.
null
50,000
lobbying_income
service_provided
[ "Issues relating to the implementation of the Affordable Care Act; issues relating to the implementation of the Generating Antibiotic Incentives Now (GAIN) Act; H.R. 4302, Protecting Access to Medicare Act; H.R. 1801, Cancer Drug Coverage Parity Act; issues relating to the 2014 Hospital Outpatient Prospective Payment System; H.R. 4187, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2014" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q1
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ", "ABBY MATOUSEK" ]
[ 31268, 55007 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/d128520d-5b95-48fd-9d2a-186c1d1a042f/print/
d128520d-5b95-48fd-9d2a-186c1d1a042f
d128520d-5b95-48fd-9d2a-186c1d1a042f_25603_133380
astellas pharma us, inc.
2014-04-17T18:31:31
YNCHF
2014-04-21T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Issues related to the development of new antibiotics. Issues related to drug safety. Issues related to CMS Outpatient Prospective Payment System (OPPS) rule." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q1
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY" ]
[ 47178, 26450, 41354 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/170a0c17-57c4-4bf1-bf1d-34f0db7f0ccc/print/
170a0c17-57c4-4bf1-bf1d-34f0db7f0ccc
170a0c17-57c4-4bf1-bf1d-34f0db7f0ccc_20744_127151
astellas pharma us, inc.
2014-04-21T19:09:28
YNCHF
2014-04-21T00:00:00
astellas pharma us, inc.
Client is a pharmaceutical company.
7,500
lobbying_income
service_provided
[ "Development of policies to advance the antimicrobial research and development environment. Support of H.R.4187 - \"DISARM Act of 2014.\"" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q1
2013-09-16
null
IL
US
393
0
0
2024-01-31T11:02:48.049026-05:00
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
286,096
Consulting
NATE GASPAR
36,969
+1 434-989-7548
[ "BARRETT THORNHILL", "JOHN MCMANUS" ]
[ 59333, 9573 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/176451/
https://lda.senate.gov/api/v1/registrants/286096/
https://lda.senate.gov/filings/public/filing/1000e545-0bb4-4c6f-a29c-b01b6f50e6f6/print/
1000e545-0bb4-4c6f-a29c-b01b6f50e6f6
1000e545-0bb4-4c6f-a29c-b01b6f50e6f6_286096_176451
astellas pharma us, inc.
2014-04-21T21:08:54
YNCHF
2014-04-21T00:00:00
astellas pharma us, inc.
null
500,000
a
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)\nCancer Drug Coverage Parity Act (H.R. 1801, S. 1879).", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152).\nIssues related to the Medicare hospital outpatient proposed rule (no specific bills).\nDeveloping an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2014 (DISARM) H.R. 4187" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q1
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK" ]
[ 54800, 59772, 54800, 59772 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/4443775f-8e13-4501-9d80-1094efe86c1e/print/
4443775f-8e13-4501-9d80-1094efe86c1e
4443775f-8e13-4501-9d80-1094efe86c1e_40032268_188248
astellas pharma us, inc.
2014-04-21T22:21:11
YNCHF
2014-04-21T00:00:00
astellas pharma us, inc.
pharmaceutical company
30,000
lobbying_income
service_provided
[ "Issues involving:?The Federal, Food, Drug and Cosmetic Act\nPatient Protection and Affordable Care Act\nThe Food and Drug Administration Safety and Innovation Act (FDASIA)", "General reimbursement issues" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q1
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "RICHARD CHARLES WHITE", "ARI MITTLEMAN", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "RICHARD CHARLES WHITE" ]
[ 64580, 54777, 58926, 56477, 64580, 56477, 54777 ]
[ null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/3bab61b4-be69-40ca-9ce7-0927bef7be61/print/
3bab61b4-be69-40ca-9ce7-0927bef7be61
3bab61b4-be69-40ca-9ce7-0927bef7be61_400762305_195037
astellas pharma us, inc.
2014-04-21T22:40:48
YNCHF
2014-06-03T00:00:00
astellas pharma us
Pharmaceutical company
25,000
lobbying_income
service_provided
[ "GENERAL HEALTH CARE ISSUES, ISSUES RELATED TO FDA, PHARMACEUTICALS" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q1
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "KENNETH LEE HODGE", "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)" ]
[ 139878, 42442, 51434, 60159 ]
[ null, null, null, "Legislative Director, Rep. Marsha Blackburn" ]
[ true, false, false, true ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/2e6fe481-9d1e-4d7d-a1b5-231a8d390e5d/print/
2e6fe481-9d1e-4d7d-a1b5-231a8d390e5d
2e6fe481-9d1e-4d7d-a1b5-231a8d390e5d_46038_153900
astellas pharma us
2014-06-03T19:12:14
YNCHF
2014-07-15T00:00:00
astellas pharma us
Pharmaceutical company
25,000
lobbying_income
service_provided
[ "GENERAL HEALTH CARE ISSUES, ISSUES RELATED TO FDA, PHARMACEUTICALS" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q2
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "KENNETH LEE HODGE", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)" ]
[ 42442, 51434, 139878, 60159 ]
[ null, null, null, "Legislative Director, Rep. Marsha Blackburn" ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/4dce6aeb-6112-4a6a-9da9-27ff8a78c6e0/print/
4dce6aeb-6112-4a6a-9da9-27ff8a78c6e0
4dce6aeb-6112-4a6a-9da9-27ff8a78c6e0_46038_153900
astellas pharma us
2014-07-15T19:49:06
YNCHF
2014-07-17T00:00:00
astellas pharma us, inc.
Client is a pharmaceutical company.
7,500
lobbying_income
service_provided
[ "Development of policies to advance the antimicrobial research and development environment. Support of H.R.4187 - \"DISARM Act of 2014.\"" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q2
2013-09-16
null
IL
US
393
0
0
2024-01-31T11:02:48.049026-05:00
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
286,096
Consulting
NATE GASPAR
36,969
+1 434-989-7548
[ "BARRETT THORNHILL", "JOHN MCMANUS" ]
[ 59333, 9573 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/176451/
https://lda.senate.gov/api/v1/registrants/286096/
https://lda.senate.gov/filings/public/filing/748e1bac-c414-4cab-a67a-dcd2f0154250/print/
748e1bac-c414-4cab-a67a-dcd2f0154250
748e1bac-c414-4cab-a67a-dcd2f0154250_286096_176451
astellas pharma us, inc.
2014-07-17T19:13:39
YNCHF
2014-07-18T00:00:00
astellas pharma us, inc.
null
50,000
lobbying_income
service_provided
[ "H.R. 4187, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2014; H.R. 4857, Ensuring Equal Access to Treatments Act of 2014" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q2
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ", "ABBY MATOUSEK" ]
[ 31268, 55007 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/ad1670db-1d2f-4bc8-98b2-80c74495c96f/print/
ad1670db-1d2f-4bc8-98b2-80c74495c96f
ad1670db-1d2f-4bc8-98b2-80c74495c96f_25603_133380
astellas pharma us, inc.
2014-07-18T14:47:44
YNCHF
2014-07-21T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q2
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY" ]
[ 47178, 26450, 41354 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/bead7de5-92ea-4883-94f4-887677ea5724/print/
bead7de5-92ea-4883-94f4-887677ea5724
bead7de5-92ea-4883-94f4-887677ea5724_20744_127151
astellas pharma us, inc.
2014-07-21T19:33:08
YNCHF
2014-07-21T00:00:00
astellas pharma us, inc.
null
470,000
a
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)\nCancer Drug Coverage Parity Act (H.R. 1801, S. 1879).\nIssues related to the Veterans Access to Care Act (H.R. 4810, S. 2450).", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152).\nIssues related to the Medicare hospital outpatient issues (H.R.4857).\nDeveloping an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2014 (DISARM) (H.R. 4187)" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q2
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK" ]
[ 54800, 59772, 54800, 59772 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/cf78d89f-3446-4235-9c32-a1900dc50f1e/print/
cf78d89f-3446-4235-9c32-a1900dc50f1e
cf78d89f-3446-4235-9c32-a1900dc50f1e_40032268_188248
astellas pharma us, inc.
2014-07-21T22:00:26
YNCHF
2014-07-21T00:00:00
astellas pharma us, inc.
pharmaceutical company
30,000
lobbying_income
service_provided
[ "General reimbursement issues", "Issues involving:?The Federal, Food, Drug and Cosmetic Act\nPatient Protection and Affordable Care Act\nThe Food and Drug Administration Safety and Innovation Act (FDASIA)" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q2
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "RICHARD CHARLES WHITE", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "RICHARD CHARLES WHITE", "ARI MITTLEMAN", "STEVEN E IRIZARRY" ]
[ 64580, 54777, 56477, 64580, 54777, 58926, 56477 ]
[ null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/1e760d75-9b3e-4f48-99d7-4d419f5532b8/print/
1e760d75-9b3e-4f48-99d7-4d419f5532b8
1e760d75-9b3e-4f48-99d7-4d419f5532b8_400762305_195037
astellas pharma us, inc.
2014-07-22T01:43:45
YNCHF
2014-10-15T00:00:00
astellas pharma us
Pharmaceutical company
25,000
lobbying_income
service_provided
[ "GENERAL HEALTH CARE ISSUES, ISSUES RELATED TO FDA, PHARMACEUTICALS" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q3
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "KENNETH LEE HODGE", "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)" ]
[ 139878, 42442, 51434, 60159 ]
[ null, null, null, "Legislative Director, Rep. Marsha Blackburn" ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/b632228c-9a33-449d-a7f2-220b034f3180/print/
b632228c-9a33-449d-a7f2-220b034f3180
b632228c-9a33-449d-a7f2-220b034f3180_46038_153900
astellas pharma us
2014-10-15T17:29:07
YNCHF
2014-10-16T00:00:00
astellas pharma us, inc.
null
50,000
lobbying_income
service_provided
[ "H.R. 4857, Ensuring Equal Access to Treatments Act of 2014; H.R. 3230, Veterans Access, Choice and Accountability Act of 2014, provisions related to prescription drug services." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q3
2007-07-01
null
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "JEREMY RABINOVITZ", "ABBY MATOUSEK" ]
[ 31268, 55007 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/449897e2-3ff8-479c-9c70-9fb90a7a87ee/print/
449897e2-3ff8-479c-9c70-9fb90a7a87ee
449897e2-3ff8-479c-9c70-9fb90a7a87ee_25603_133380
astellas pharma us, inc.
2014-10-16T18:05:51
YNCHF
2014-10-19T00:00:00
astellas pharma us, inc.
pharmaceutical company
30,000
lobbying_income
service_provided
[ "Issues involving:?The Federal, Food, Drug and Cosmetic Act\nPatient Protection and Affordable Care Act\nThe Food and Drug Administration Safety and Innovation Act (FDASIA)", "General reimbursement issues" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q3
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "RICHARD CHARLES WHITE", "ARI MITTLEMAN", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "RICHARD CHARLES WHITE", "STEVEN E IRIZARRY" ]
[ 64580, 54777, 58926, 56477, 64580, 54777, 56477 ]
[ null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/cfae543f-2842-4222-b9c1-fc4cd24f00f1/print/
cfae543f-2842-4222-b9c1-fc4cd24f00f1
cfae543f-2842-4222-b9c1-fc4cd24f00f1_400762305_195037
astellas pharma us, inc.
2014-10-20T00:26:46
YNCHF
2014-10-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q3
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY" ]
[ 47178, 26450, 41354 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/79abfc41-a2b9-4dcf-8e9d-43670f98fada/print/
79abfc41-a2b9-4dcf-8e9d-43670f98fada
79abfc41-a2b9-4dcf-8e9d-43670f98fada_20744_127151
astellas pharma us, inc.
2014-10-20T19:20:26
YNCHF
2014-10-20T00:00:00
astellas pharma us, inc.
Client is a pharmaceutical company.
7,500
lobbying_income
service_provided
[ "Development of policies to advance the antimicrobial research and development environment. Support of H.R.4187 - \"DISARM Act of 2014.\"" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q3
2013-09-16
null
IL
US
393
0
0
2024-01-31T11:02:48.049026-05:00
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
286,096
Consulting
NATE GASPAR
36,969
+1 434-989-7548
[ "BARRETT THORNHILL", "JOHN MCMANUS" ]
[ 59333, 9573 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/176451/
https://lda.senate.gov/api/v1/registrants/286096/
https://lda.senate.gov/filings/public/filing/b680fa57-7c82-43e7-9165-91016e816990/print/
b680fa57-7c82-43e7-9165-91016e816990
b680fa57-7c82-43e7-9165-91016e816990_286096_176451
astellas pharma us, inc.
2014-10-20T20:05:16
YNCHF
2014-10-20T00:00:00
astellas pharma us, inc.
null
400,000
a
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152)\nCancer Drug Coverage Parity Act (H.R. 1801, S. 1879).", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152).\nIssues related to the Medicare hospital outpatient issues (H.R.4857).\nDeveloping an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2014 (DISARM) (H.R. 4187)" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q3
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK" ]
[ 54800, 59772, 54800, 59772 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/ad5b15fe-bf81-4a10-bada-71971335b05a/print/
ad5b15fe-bf81-4a10-bada-71971335b05a
ad5b15fe-bf81-4a10-bada-71971335b05a_40032268_188248
astellas pharma us, inc.
2014-10-20T22:24:45
YNCHF
2014-11-01T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q4
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/519352ad-9503-40a1-b417-2706dc15986a/print/
519352ad-9503-40a1-b417-2706dc15986a
519352ad-9503-40a1-b417-2706dc15986a_305054_181397
astellas pharma us, inc.
null
YNCHF
2015-01-07T00:00:00
astellas pharma us
Pharmaceutical company
25,000
lobbying_income
service_provided
[ "GENERAL HEALTH CARE ISSUES, ISSUES RELATED TO FDA, PHARMACEUTICALS" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q4
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "KENNETH LEE HODGE", "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)" ]
[ 139878, 42442, 51434, 60159 ]
[ null, null, null, "Legislative Director, Rep. Marsha Blackburn" ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/09a4336c-bbe8-49f0-8b87-38723160e028/print/
09a4336c-bbe8-49f0-8b87-38723160e028
09a4336c-bbe8-49f0-8b87-38723160e028_46038_153900
astellas pharma us
2015-01-07T20:59:21
YNCHF
2015-01-20T00:00:00
astellas pharma us, inc.
null
50,000
lobbying_income
terminate
[ "H.R.4857, Ensuring Equal Access to Treatments Act of 2014; H.R. 3230, Veterans Access, Accountability Act of 2014, provisions related to prescription drug services." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q4
2007-07-01
2014-11-30
IL
US
1,002,983
0
null
2024-01-30T12:37:26.892278-05:00
ML STRATEGIES, LLC
555 12th Street NW, Suite 1100, Washington, DC, 20004, US
25,603
Government relations consulting firm
KENISHA RUSSELL
33,962
+1 202-434-7310
[ "ABBY MATOUSEK", "JEREMY RABINOVITZ" ]
[ 55007, 31268 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/133380/
https://lda.senate.gov/api/v1/registrants/25603/
https://lda.senate.gov/filings/public/filing/d936c063-0cbb-4ff4-a4cd-c8fb8eede8bd/print/
d936c063-0cbb-4ff4-a4cd-c8fb8eede8bd
d936c063-0cbb-4ff4-a4cd-c8fb8eede8bd_25603_133380
astellas pharma us, inc.
2015-01-20T14:49:36
YNCHF
2015-01-20T00:00:00
astellas pharma us, inc.
Client is a pharmaceutical company.
7,500
lobbying_income
service_provided
[ "Development of policies to advance the antimicrobial research and development environment. Support of H.R.4187 - \"DISARM Act of 2014.\"" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q4
2013-09-16
null
IL
US
393
0
0
2024-01-31T11:02:48.049026-05:00
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
286,096
Consulting
NATE GASPAR
36,969
+1 434-989-7548
[ "BARRETT THORNHILL", "JOHN MCMANUS" ]
[ 59333, 9573 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/176451/
https://lda.senate.gov/api/v1/registrants/286096/
https://lda.senate.gov/filings/public/filing/2e612a1c-4bf0-4c42-96d6-6623d223aa33/print/
2e612a1c-4bf0-4c42-96d6-6623d223aa33
2e612a1c-4bf0-4c42-96d6-6623d223aa33_286096_176451
astellas pharma us, inc.
2015-01-20T19:50:08
YNCHF
2015-01-20T00:00:00
astellas pharma us, inc.
pharmaceutical company
30,000
lobbying_income
service_provided
[ "Issues involving: The Federal, Food, Drug and Cosmetic Act\nPatient Protection and Affordable Care Act\nThe Food and Drug Administration Safety and Innovation Act (FDASIA)", "General reimbursement issues\nH.R. 4857/S.2980 Ensuring Equal Access to Treatments Act" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q4
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "RICHARD CHARLES WHITE", "ARI MITTLEMAN", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "RICHARD CHARLES WHITE", "STEVEN E IRIZARRY" ]
[ 64580, 54777, 58926, 56477, 64580, 54777, 56477 ]
[ null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/b89bf3b6-a4eb-44e0-912e-be1063628c8e/print/
b89bf3b6-a4eb-44e0-912e-be1063628c8e
b89bf3b6-a4eb-44e0-912e-be1063628c8e_400762305_195037
astellas pharma us, inc.
2015-01-20T20:00:38
YNCHF
2015-01-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q4
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY" ]
[ 47178, 26450, 41354 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/b0fe0cb3-dd1b-4c9f-84e5-9f0cbf56a844/print/
b0fe0cb3-dd1b-4c9f-84e5-9f0cbf56a844
b0fe0cb3-dd1b-4c9f-84e5-9f0cbf56a844_20744_127151
astellas pharma us, inc.
2015-01-20T21:15:06
YNCHF
2015-01-20T00:00:00
astellas pharma us, inc.
null
440,000
a
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152); Cancer Drug Coverage Parity Act (H.R. 1801, S. 1879).", "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152); Issues related to the Medicare hospital outpatient issues (H.R. 4857, S. 2980); Developing an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2014 (DISARM) (H.R. 4187)" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q4
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "MELISSA WIER BANASHAK", "MARY LACEY REUTHER" ]
[ 54800, 59772, 59772, 54800 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/28e3ea3e-7e69-4f0f-bcfd-347735fbf7ca/print/
28e3ea3e-7e69-4f0f-bcfd-347735fbf7ca
28e3ea3e-7e69-4f0f-bcfd-347735fbf7ca_40032268_188248
astellas pharma us, inc.
2015-01-20T22:46:45
YNCHF
2015-01-21T00:00:00
astellas pharma us, inc.
Pharmaceuticals
30,000
lobbying_income
service_provided
[ "H.R. 4857, Ensuring Equal Access to Treatments Act of 2014; S. 2980, Ensuring Equal Access to Treatments Act" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2014-Q4
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/74f826d1-d49f-43be-a5c8-e11e08fa7c9a/print/
74f826d1-d49f-43be-a5c8-e11e08fa7c9a
74f826d1-d49f-43be-a5c8-e11e08fa7c9a_305054_181397
astellas pharma us, inc.
2015-01-21T02:46:11
YNCHF
2015-04-15T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "GENERAL HEALTH CARE ISSUES, ISSUES RELATED TO FDA, PHARMACEUTICALS" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q1
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "KENNETH LEE HODGE", "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)" ]
[ 139878, 42442, 51434, 60159 ]
[ null, null, null, "Legislative Director, Rep. Marsha Blackburn" ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/89aee980-8e0e-4e27-858f-74d24712582d/print/
89aee980-8e0e-4e27-858f-74d24712582d
89aee980-8e0e-4e27-858f-74d24712582d_46038_153900
astellas pharma us
2015-04-15T17:26:23
YNCHF
2015-04-20T00:00:00
astellas pharma us, inc.
pharmaceutical company
30,000
lobbying_income
service_provided
[ "Issues involving: The Federal, Food, Drug and Cosmetic Act\n Patient Protection and Affordable Care Act\n The Food and Drug Administration Safety and Innovation Act (FDASIA)", "General reimbursement issues\n H.R. 1178 - Ensuring Equal Access to Treatments Act - all provisions" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q1
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "ARI MITTLEMAN", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY" ]
[ 64580, 56477, 58926, 64580, 56477 ]
[ null, null, null, null, null ]
[ false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/b37d0fc2-b267-4abf-9925-a47dbabf3b37/print/
b37d0fc2-b267-4abf-9925-a47dbabf3b37
b37d0fc2-b267-4abf-9925-a47dbabf3b37_400762305_195037
astellas pharma us, inc.
2015-04-20T16:49:28
YNCHF
2015-04-20T00:00:00
astellas pharma us, inc.
Client is a pharmaceutical company.
10,000
lobbying_income
service_provided
[ "Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - \"DISARM Act of 2015.\"" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q1
2013-09-16
null
IL
US
393
0
0
2024-01-31T11:02:48.049026-05:00
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
286,096
Consulting
NATE GASPAR
36,969
+1 434-989-7548
[ "BARRETT THORNHILL", "JOHN MCMANUS", "CHASE M THOMAS", "LINDSAY BEALOR" ]
[ 59333, 9573, 63271, 55515 ]
[ null, null, null, null ]
[ false, false, true, false ]
https://lda.senate.gov/api/v1/clients/176451/
https://lda.senate.gov/api/v1/registrants/286096/
https://lda.senate.gov/filings/public/filing/d37db2a7-e352-4139-b909-433cde2fd9a4/print/
d37db2a7-e352-4139-b909-433cde2fd9a4
d37db2a7-e352-4139-b909-433cde2fd9a4_286096_176451
astellas pharma us, inc.
2015-04-20T18:01:46
YNCHF
2015-04-20T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "HR 1178 Ensuring Equal Access to Treatments Act" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q1
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/66e461f5-2480-4296-8aa8-818b81d43a5f/print/
66e461f5-2480-4296-8aa8-818b81d43a5f
66e461f5-2480-4296-8aa8-818b81d43a5f_305054_181397
astellas pharma us, inc.
2015-04-20T19:54:25
YNCHF
2015-04-20T00:00:00
astellas pharma us, inc.
null
440,000
a
service_provided
[ "Issues related to the implementation of healthcare reform (P.L.111-148, P.L.111-152); Cancer Drug Coverage Parity Act (H.R.1801, S.1879).", "Issues related to the implementation of health care reform (P.L.111-148, P.L.111-152); Issues related to the Medicare hospital outpatient issues (H.R.4857, S.2980); Developing an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2014 (DISARM) (H.R.4187)" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q1
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK" ]
[ 54800, 59772, 54800, 59772 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/8c2c5e3e-9704-400f-88a0-51eb9f9d7503/print/
8c2c5e3e-9704-400f-88a0-51eb9f9d7503
8c2c5e3e-9704-400f-88a0-51eb9f9d7503_40032268_188248
astellas pharma us, inc.
2015-04-20T22:25:32
YNCHF
2015-04-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
70,000
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule. H.R. 1178, Ensuring Equal Access to Treatments Act of 2015." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q1
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY" ]
[ 47178, 26450, 41354 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/f42fa61c-f386-4837-8706-0b8f9632d3aa/print/
f42fa61c-f386-4837-8706-0b8f9632d3aa
f42fa61c-f386-4837-8706-0b8f9632d3aa_20744_127151
astellas pharma us, inc.
2015-04-21T00:09:30
YNCHF
2015-07-17T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "GENERAL HEALTH CARE ISSUES, ISSUES RELATED TO FDA, PHARMACEUTICALS" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q2
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "KENNETH LEE HODGE", "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)" ]
[ 139878, 42442, 51434, 60159 ]
[ null, null, null, "Legislative Director, Rep. Marsha Blackburn" ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/406d6c58-48e8-4400-8409-00dbaebc6140/print/
406d6c58-48e8-4400-8409-00dbaebc6140
406d6c58-48e8-4400-8409-00dbaebc6140_46038_153900
astellas pharma us
2015-07-17T17:22:34
YNCHF
2015-07-17T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "HR.1178 and S.1466, Ensuring Equal Access to Treatments Act; HR.6, 21st Century Cures Act" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q2
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/7ea1564c-6b3e-4b7f-81d0-546dca8e19c5/print/
7ea1564c-6b3e-4b7f-81d0-546dca8e19c5
7ea1564c-6b3e-4b7f-81d0-546dca8e19c5_305054_181397
astellas pharma us, inc.
2015-07-17T15:47:53
YNCHF
2015-07-20T00:00:00
astellas pharma us, inc.
pharmaceutical company
30,000
lobbying_income
service_provided
[ "Issues involving: The Federal, Food, Drug and Cosmetic Act\n The Food and Drug Administration Safety and Innovation Act (FDASIA)", "General reimbursement issues\n H.R. 1178 - Ensuring Equal Access to Treatments Act - all provisions" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q2
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "ARI MITTLEMAN", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY" ]
[ 64580, 56477, 58926, 64580, 56477 ]
[ null, null, null, null, null ]
[ false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/bee50219-3278-4695-95f0-ff851136b17f/print/
bee50219-3278-4695-95f0-ff851136b17f
bee50219-3278-4695-95f0-ff851136b17f_400762305_195037
astellas pharma us, inc.
2015-07-20T19:26:38
YNCHF
2015-07-20T00:00:00
astellas pharma us, inc.
null
710,000
a
service_provided
[ "Issues related to the implementation of health care reform (P.L.111-148, P.L.111-152); Issues related to the Medicare hospital outpatient issues (H.R.1178, S.1466); Developing an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2015 (DISARM) (H.R.512)", "Issues related to various patent reform bills (H.R.9, S.632, S.1137).", "Issues related to the implementation of healthcare reform (P.L.111-148, P.L.111-152); Issues related to oral chemotherapy in The Cancer Drug Coverage Parity Act (S.1566, H.R.2739); The 21st Century Cures Act (H.R.6)." ]
[ "MMM - Medicare/Medicaid", "CPT - Copyright/Patent/Trademark", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q2
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK" ]
[ 54800, 59772, 54800, 59772, 54800, 59772 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/d11c2f62-0bdd-4663-bbaf-10fe77cab3a8/print/
d11c2f62-0bdd-4663-bbaf-10fe77cab3a8
d11c2f62-0bdd-4663-bbaf-10fe77cab3a8_40032268_188248
astellas pharma us, inc.
2015-07-20T19:44:17
YNCHF
2015-07-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule. H.R. 1178, Ensuring Equal Access to Treatments Act of 2015. S.1466, Ensuring Equal Access to Treatments Act of 2015." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q2
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY" ]
[ 47178, 26450, 41354 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/decf8dd4-ab9f-423e-911c-cdab600e425f/print/
decf8dd4-ab9f-423e-911c-cdab600e425f
decf8dd4-ab9f-423e-911c-cdab600e425f_20744_127151
astellas pharma us, inc.
2015-07-20T20:50:35
YNCHF
2015-07-20T00:00:00
astellas pharma us, inc.
Client is a pharmaceutical company.
10,000
lobbying_income
service_provided
[ "Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q2
2013-09-16
null
IL
US
393
0
0
2024-01-31T11:02:48.049026-05:00
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
286,096
Consulting
NATE GASPAR
36,969
+1 434-989-7548
[ "BARRETT THORNHILL", "JOHN MCMANUS", "CHASE M THOMAS" ]
[ 59333, 9573, 63271 ]
[ null, null, null ]
[ false, false, true ]
https://lda.senate.gov/api/v1/clients/176451/
https://lda.senate.gov/api/v1/registrants/286096/
https://lda.senate.gov/filings/public/filing/ba1c8d5c-6424-4ec4-8d96-c23934ad373d/print/
ba1c8d5c-6424-4ec4-8d96-c23934ad373d
ba1c8d5c-6424-4ec4-8d96-c23934ad373d_286096_176451
astellas pharma us, inc.
2015-07-20T21:01:50
YNCHF
2015-10-20T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "GENERAL HEALTH CARE ISSUES, ISSUES RELATED TO FDA, PHARMACEUTICALS" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q3
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "KENNETH LEE HODGE" ]
[ 42442, 51434, 60159, 139878 ]
[ null, null, "Legislative Director, Rep. Marsha Blackburn", null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/6b8e34b3-ab59-4ef4-8498-a82cbeea3a2b/print/
6b8e34b3-ab59-4ef4-8498-a82cbeea3a2b
6b8e34b3-ab59-4ef4-8498-a82cbeea3a2b_46038_153900
astellas pharma us
2015-10-20T22:41:01
YNCHF
2015-10-20T00:00:00
astellas pharma us, inc.
pharmaceutical company
30,000
lobbying_income
service_provided
[ "General reimbursement issues\n H.R. 1178 - Ensuring Equal Access to Treatments Act - all provisions", "Issues involving: The Federal, Food, Drug and Cosmetic Act\n The Food and Drug Administration Safety and Innovation Act (FDASIA)" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q3
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY" ]
[ 64580, 56477, 64580, 56477 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/be247eed-3173-4d98-a233-e83352313a52/print/
be247eed-3173-4d98-a233-e83352313a52
be247eed-3173-4d98-a233-e83352313a52_400762305_195037
astellas pharma us, inc.
2015-10-20T15:40:08
YNCHF
2015-10-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule. H.R. 1178, Ensuring Equal Access to Treatments Act of 2015. S.1466, Ensuring Equal Access to Treatments Act of 2015." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q3
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY" ]
[ 47178, 26450, 41354 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/d8fe4054-1f6d-4b33-8978-9c698221be9b/print/
d8fe4054-1f6d-4b33-8978-9c698221be9b
d8fe4054-1f6d-4b33-8978-9c698221be9b_20744_127151
astellas pharma us, inc.
2015-10-20T19:11:49
YNCHF
2015-10-20T00:00:00
astellas pharma us, inc.
null
680,000
a
service_provided
[ "Issues related to various patent reform bills (H.R.9, S.632, S.1137).", "Issues related to the implementation of healthcare reform (P.L.111-148, P.L.111-152); Issues related to oral chemotherapy in The Cancer Drug Coverage Parity Act (S.1566, H.R.2739); The 21st Century Cures Act (H.R.6).", "Issues related to the implementation of health care reform (P.L.111-148, P.L.111-152); Issues related to the Medicare hospital outpatient issues (H.R.1178, S.1466); Developing an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2015 (DISARM) (H.R.512)" ]
[ "CPT - Copyright/Patent/Trademark", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q3
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK" ]
[ 54800, 59772, 54800, 59772, 54800, 59772 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/7b59b77e-5aa3-4c0d-b152-5f111c7ecfff/print/
7b59b77e-5aa3-4c0d-b152-5f111c7ecfff
7b59b77e-5aa3-4c0d-b152-5f111c7ecfff_40032268_188248
astellas pharma us, inc.
2015-10-20T21:55:14
YNCHF
2015-10-20T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "HR.1178 and S.1466, Ensuring Equal Access to Treatments Act; HR.6, 21st Century Cures Act; HR 2739, Cancer Drug Coverage Parity Act of 2015" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q3
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/134bc33c-c4d5-4bc4-94ce-5c4cfdefc754/print/
134bc33c-c4d5-4bc4-94ce-5c4cfdefc754
134bc33c-c4d5-4bc4-94ce-5c4cfdefc754_305054_181397
astellas pharma us, inc.
2015-10-21T02:13:34
YNCHF
2015-10-22T00:00:00
astellas pharma us, inc.
Client is a pharmaceutical company.
10,000
lobbying_income
terminate_retainer
[]
null
null
2015-Q3
2013-09-16
2015-09-30
IL
US
393
0
0
2024-01-31T11:02:48.049026-05:00
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
286,096
Consulting
NATE GASPAR
36,969
+1 434-989-7548
null
null
null
null
https://lda.senate.gov/api/v1/clients/176451/
https://lda.senate.gov/api/v1/registrants/286096/
https://lda.senate.gov/filings/public/filing/d258eae1-6422-4b0c-a306-b30a1c3ac02a/print/
d258eae1-6422-4b0c-a306-b30a1c3ac02a
d258eae1-6422-4b0c-a306-b30a1c3ac02a_286096_176451
astellas pharma us, inc.
2015-10-22T18:28:46
YNCHF
2016-01-20T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "GENERAL HEALTH CARE ISSUES, ISSUES RELATED TO FDA, PHARMACEUTICALS" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q4
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "KENNETH LEE HODGE" ]
[ 42442, 51434, 60159, 139878 ]
[ null, null, "Legislative Director, Rep. Marsha Blackburn", null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/84c4223b-f26d-48fa-b071-dd3e13e1f399/print/
84c4223b-f26d-48fa-b071-dd3e13e1f399
84c4223b-f26d-48fa-b071-dd3e13e1f399_46038_153900
astellas pharma us
2016-01-20T19:39:06
YNCHF
2016-01-20T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "HR.1178 and S.1466, Ensuring Equal Access to Treatments Act; HR 2739, Cancer Drug Coverage Parity Act of 2015" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q4
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/daf0addd-c2dc-47d8-9fd5-e61dac2fb090/print/
daf0addd-c2dc-47d8-9fd5-e61dac2fb090
daf0addd-c2dc-47d8-9fd5-e61dac2fb090_305054_181397
astellas pharma us, inc.
2016-01-20T01:59:29
YNCHF
2016-01-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule. H.R. 1178, Ensuring Equal Access to Treatments Act of 2015. S.1466, Ensuring Equal Access to Treatments Act of 2015." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q4
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY" ]
[ 47178, 26450, 41354 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/079d3d10-b1f2-4e87-9aab-94fcc2f85511/print/
079d3d10-b1f2-4e87-9aab-94fcc2f85511
079d3d10-b1f2-4e87-9aab-94fcc2f85511_20744_127151
astellas pharma us, inc.
2016-01-20T16:06:40
YNCHF
2016-01-21T00:00:00
astellas pharma us, inc.
null
680,000
a
service_provided
[ "Issues related to various patent reform bills (H.R.9, S.632, S.1137).", "Issues related to the implementation of healthcare reform (P.L.111-148, P.L.111-152); Issues related to oral chemotherapy in The Cancer Drug Coverage Parity Act (S.1566, H.R.2739); The 21st Century Cures Act (H.R.6).", "Issues related to the implementation of health care reform (P.L.111-148, P.L.111-152); Issues related to the Medicare hospital outpatient issues (H.R.1178, S.1466); Developing an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2015 (DISARM) (H.R.512)" ]
[ "CPT - Copyright/Patent/Trademark", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q4
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK" ]
[ 54800, 59772, 54800, 59772, 54800, 59772 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/00cef21e-7d3c-4b53-a2b4-e74553f15b6c/print/
00cef21e-7d3c-4b53-a2b4-e74553f15b6c
00cef21e-7d3c-4b53-a2b4-e74553f15b6c_40032268_188248
astellas pharma us, inc.
2016-01-21T00:33:32
YNCHF
2016-01-21T00:00:00
astellas pharma us, inc.
pharmaceutical company
30,000
lobbying_income
service_provided
[ "Issues involving: The Federal, Food, Drug and Cosmetic Act\n The Food and Drug Administration Safety and Innovation Act (FDASIA)", "General reimbursement issues\n H.R. 1178 - Ensuring Equal Access to Treatments Act - all provisions" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2015-Q4
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY" ]
[ 64580, 56477, 64580, 56477 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/db6e7ba1-4bfd-48b5-9fab-e9a28225d7f1/print/
db6e7ba1-4bfd-48b5-9fab-e9a28225d7f1
db6e7ba1-4bfd-48b5-9fab-e9a28225d7f1_400762305_195037
astellas pharma us, inc.
2016-01-21T03:47:06
YNCHF
2016-04-18T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "HR.1178 and S.1466, Ensuring Equal Access to Treatments Act; HR 2739, Cancer Drug Coverage Parity Act of 2015; Issues related to P.L. 96-517, the Bayh-Dole Act." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q1
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/cc22a44f-195f-4755-a809-0e401835728a/print/
cc22a44f-195f-4755-a809-0e401835728a
cc22a44f-195f-4755-a809-0e401835728a_305054_181397
astellas pharma us, inc.
2016-04-18T18:34:36
YNCHF
2016-04-19T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "GENERAL HEALTH CARE ISSUES, ISSUES RELATED TO FDA, PHARMACEUTICALS" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q1
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "KENNETH LEE HODGE" ]
[ 42442, 51434, 60159, 139878 ]
[ null, null, "Legislative Director, Rep. Marsha Blackburn", null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/c7d49463-47d6-4b16-bf82-19da7c236d3f/print/
c7d49463-47d6-4b16-bf82-19da7c236d3f
c7d49463-47d6-4b16-bf82-19da7c236d3f_46038_153900
astellas pharma us
2016-04-19T18:36:05
YNCHF
2016-04-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule. H.R. 1178, Ensuring Equal Access to Treatments Act of 2015. S.1466, Ensuring Equal Access to Treatments Act of 2015. Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517)." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q1
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SHEILA MURPHY" ]
[ 47178, 26450, 41354 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/d65d9dd1-bf8c-4545-809a-a385e67da9bb/print/
d65d9dd1-bf8c-4545-809a-a385e67da9bb
d65d9dd1-bf8c-4545-809a-a385e67da9bb_20744_127151
astellas pharma us, inc.
2016-04-20T20:18:27
YNCHF
2016-04-20T00:00:00
astellas pharma us, inc.
pharmaceutical company
30,000
lobbying_income
service_provided
[ "General reimbursement issues\n H.R. 1178 - Ensuring Equal Access to Treatments Act - all provisions", "Issues involving: The Federal, Food, Drug and Cosmetic Act\n The Food and Drug Administration Safety and Innovation Act (FDASIA)\n- Bayh-Dole Act/march in authority" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q1
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY" ]
[ 64580, 56477, 64580, 56477 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/3096121e-5faf-40c0-a953-c3b326623cc5/print/
3096121e-5faf-40c0-a953-c3b326623cc5
3096121e-5faf-40c0-a953-c3b326623cc5_400762305_195037
astellas pharma us, inc.
2016-04-20T22:19:09
YNCHF
2016-04-20T00:00:00
astellas pharma us, inc.
null
680,000
a
service_provided
[ "Issues related to various patent reform bills (H.R.9, S.632, S.1137).", "Issues related to the implementation of healthcare reform (P.L.111-148, P.L.111-152); Issues related to oral chemotherapy in The Cancer Drug Coverage Parity Act (S.1566, H.R.2739); The 21st Century Cures Act (H.R.6).", "Issues related to the implementation of health care reform (P.L.111-148, P.L.111-152); Issues related to the Medicare hospital outpatient issues (H.R.1178, S.1466); Developing an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2015 (DISARM) (H.R.512)" ]
[ "CPT - Copyright/Patent/Trademark", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q1
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE (Professional Staff for Rep. Tom Davis; Clerk for Rep. Todd Platts; Intern for Sen. Rick Santorum)", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE (Professional Staff for Rep. Tom Davis; Clerk for Rep. Todd Platts; Intern for Sen. Rick Santorum)", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE (Professional Staff for Rep. Tom Davis; Clerk for Rep. Todd Platts; Intern for Sen. Rick Santorum)" ]
[ 54800, 59772, 64567, 54800, 59772, 64567, 54800, 59772, 64567 ]
[ null, null, "Professional Staff for Rep. Tom Davis; Clerk for Rep. Todd Platts; Intern for Sen. Rick Santorum", null, null, "Professional Staff for Rep. Tom Davis; Clerk for Rep. Todd Platts; Intern for Sen. Rick Santorum", null, null, "Professional Staff for Rep. Tom Davis; Clerk for Rep. Todd Platts; Intern for Sen. Rick Santorum" ]
[ false, false, true, false, false, true, false, false, true ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/cdf89980-b886-485a-9a75-e8eec02ec52e/print/
cdf89980-b886-485a-9a75-e8eec02ec52e
cdf89980-b886-485a-9a75-e8eec02ec52e_40032268_188248
astellas pharma us, inc.
2016-04-20T23:53:28
YNCHF
2016-07-07T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "GENERAL HEALTH CARE ISSUES, ISSUES RELATED TO FDA, PHARMACEUTICALS" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q2
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "KENNETH LEE HODGE" ]
[ 42442, 51434, 60159, 139878 ]
[ null, null, "Legislative Director, Rep. Marsha Blackburn", null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/c09fd3a7-799b-4a7c-b267-5f41770f950d/print/
c09fd3a7-799b-4a7c-b267-5f41770f950d
c09fd3a7-799b-4a7c-b267-5f41770f950d_46038_153900
astellas pharma us
2016-07-07T20:30:45
YNCHF
2016-07-15T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "HR.1178 and S.1466, Ensuring Equal Access to Treatments Act; HR 2739, Cancer Drug Coverage Parity Act of 2015; Issues related to P.L. 96-517, the Bayh-Dole Act.", "H.R. 4923, American Manufacturing Competitiveness Act." ]
[ "HCR - Health Issues", "TRD - Trade (domestic/foreign)" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q2
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ", "JEREMY RABINOVITZ" ]
[ 61187, 61187 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/3a1907d9-57e2-40c1-b7ce-fc1354c0ecae/print/
3a1907d9-57e2-40c1-b7ce-fc1354c0ecae
3a1907d9-57e2-40c1-b7ce-fc1354c0ecae_305054_181397
astellas pharma us, inc.
2016-07-15T17:27:21
YNCHF
2016-07-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule. H.R. 1178, Ensuring Equal Access to Treatments Act of 2015. S.1466, Ensuring Equal Access to Treatments Act of 2015. Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517)." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q2
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SEAN RICHARDSON", "SHEILA MURPHY" ]
[ 47178, 26450, 6542, 41354 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/5421fdd1-6dbb-410c-9266-66d698f7eded/print/
5421fdd1-6dbb-410c-9266-66d698f7eded
5421fdd1-6dbb-410c-9266-66d698f7eded_20744_127151
astellas pharma us, inc.
2016-07-20T14:04:18
YNCHF
2016-07-20T00:00:00
astellas pharma us, inc.
null
680,000
a
service_provided
[ "Issues related to various patent reform bills (H.R.9, S.632, S.1137).", "Issues related to the implementation of healthcare reform (P.L.111-148, P.L.111-152); Issues related to oral chemotherapy in The Cancer Drug Coverage Parity Act (S.1566, H.R.2739); The 21st Century Cures Act (H.R.6).", "Issues related to the implementation of health care reform (P.L.111-148, P.L.111-152); Issues related to the Medicare hospital outpatient issues (H.R.1178, S.1466); Developing an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2015 (DISARM) (H.R.512)" ]
[ "CPT - Copyright/Patent/Trademark", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q2
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE (Professional Staff for Rep. Tom Davis; Clerk for Rep. Todd Platts; Intern for Sen. Rick Santorum)", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE" ]
[ 54800, 59772, 64567, 54800, 59772, 64567, 54800, 59772, 64567 ]
[ null, null, "Professional Staff for Rep. Tom Davis; Clerk for Rep. Todd Platts; Intern for Sen. Rick Santorum", null, null, null, null, null, null ]
[ false, false, true, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/cd489f72-368f-42e5-81cb-c09e84d911ec/print/
cd489f72-368f-42e5-81cb-c09e84d911ec
cd489f72-368f-42e5-81cb-c09e84d911ec_40032268_188248
astellas pharma us, inc.
2016-07-20T20:12:25
YNCHF
2016-07-20T00:00:00
astellas pharma us, inc.
pharmaceutical company
50,000
lobbying_income
service_provided
[ "Issues involving: The Federal, Food, Drug and Cosmetic Act\n The Food and Drug Administration Safety and Innovation Act (FDASIA)\n- Bayh-Dole Act/march in authority", "General reimbursement issues\n H.R. 1178 - Ensuring Equal Access to Treatments Act - all provisions" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q2
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY" ]
[ 64580, 56477, 64580, 56477 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/d36117dc-f6ad-4c2d-9dcb-3e1d8e0bc164/print/
d36117dc-f6ad-4c2d-9dcb-3e1d8e0bc164
d36117dc-f6ad-4c2d-9dcb-3e1d8e0bc164_400762305_195037
astellas pharma us, inc.
2016-07-20T20:22:58
YNCHF
2016-10-12T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "GENERAL HEALTH CARE ISSUES, ISSUES RELATED TO FDA, PHARMACEUTICALS" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q3
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "KENNETH LEE HODGE", "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)" ]
[ 139878, 42442, 51434, 60159 ]
[ null, null, null, "Legislative Director, Rep. Marsha Blackburn" ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/c281465d-7dc4-49ec-9fa4-6b8665e0b4d2/print/
c281465d-7dc4-49ec-9fa4-6b8665e0b4d2
c281465d-7dc4-49ec-9fa4-6b8665e0b4d2_46038_153900
astellas pharma us
2016-10-12T17:00:50
YNCHF
2016-10-17T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "HR.1178 and S.1466, Ensuring Equal Access to Treatments Act; HR 2739, Cancer Drug Coverage Parity Act of 2015; Issues related to P.L. 96-517, the Bayh-Dole Act." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q3
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/0f813fac-11e5-4e74-b70e-582113f9a5c4/print/
0f813fac-11e5-4e74-b70e-582113f9a5c4
0f813fac-11e5-4e74-b70e-582113f9a5c4_305054_181397
astellas pharma us, inc.
2016-10-17T16:36:53
YNCHF
2016-10-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
0
lobbying_income
service_provided
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule. H.R. 1178, Ensuring Equal Access to Treatments Act of 2015. S.1466, Ensuring Equal Access to Treatments Act of 2015. Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517)." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q3
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SEAN RICHARDSON", "SHEILA MURPHY" ]
[ 47178, 26450, 6542, 41354 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/ffc7f177-2b4d-4262-bb90-4769e0b935dd/print/
ffc7f177-2b4d-4262-bb90-4769e0b935dd
ffc7f177-2b4d-4262-bb90-4769e0b935dd_20744_127151
astellas pharma us, inc.
2016-10-20T13:47:49
YNCHF
2016-10-20T00:00:00
astellas pharma us, inc.
pharmaceutical company
50,000
lobbying_income
service_provided
[ "- The Federal, Food, Drug and Cosmetic Act\n- The Food and Drug Administration Safety and Innovation Act (FDASIA)\n- Bayh-Dole Act/ march in authority", "- CMMI Part B Drug Payment Demonstration Program\n- General reimbursement issues\n- H.R. 1178- Ensuring Equal Access to Treatments Act- all provisions" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q3
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY" ]
[ 64580, 56477, 64580, 56477 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/cad3bcc1-1967-48d0-8192-dac5b427e00f/print/
cad3bcc1-1967-48d0-8192-dac5b427e00f
cad3bcc1-1967-48d0-8192-dac5b427e00f_400762305_195037
astellas pharma us, inc.
2016-10-20T19:02:52
YNCHF
2016-10-20T00:00:00
astellas pharma us, inc.
null
420,000
a
service_provided
[ "Issues related to various patent reform bills (H.R.9, S.632, S.1137).", "Proposed Regulations under IRC Sec. 385 regarding their impact on the ability of U.S. subsidiaries to invest and grow in the United States and the competitiveness of the United States as a location for foreign direct investment.", "Issues related to the implementation of healthcare reform (P.L.111-148, P.L.111-152); Issues related to oral chemotherapy in The Cancer Drug Coverage Parity Act (S.1566, H.R.2739); The 21st Century Cures Act (H.R.6); Food and Drug Administration Safety and Innovation Act (FDASIA) policy issues; Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517).", "Issues related to the implementation of health care reform (P.L.111-148, P.L.111-152); Issues related to the Medicare hospital outpatient issues (H.R.1178, S.1466); Developing an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2015 (DISARM) (H.R.512); Medicare Program; Part B Drug Payment Model, Proposed rule, CMS-1670-P (March 11, 2016) - Provisions related to the Medicare Part B Drug Payment Model; H.R. 5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models - Suspending the Part B Drug Payment Model; Medicare Part D rebates policy issues." ]
[ "CPT - Copyright/Patent/Trademark", "TAX - Taxation/Internal Revenue Code", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q3
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE (Professional Staff for Rep. Tom Davis; Clerk for Rep. Todd Platts; Intern for Sen. Rick Santorum)", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE" ]
[ 54800, 59772, 64567, 54800, 59772, 64567, 54800, 59772, 64567, 54800, 59772, 64567 ]
[ null, null, "Professional Staff for Rep. Tom Davis; Clerk for Rep. Todd Platts; Intern for Sen. Rick Santorum", null, null, null, null, null, null, null, null, null ]
[ false, false, true, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/1486a2d7-0265-4ee8-9491-29075ee417b3/print/
1486a2d7-0265-4ee8-9491-29075ee417b3
1486a2d7-0265-4ee8-9491-29075ee417b3_40032268_188248
astellas pharma us, inc.
2016-10-20T19:16:42
YNCHF
2017-04-11T00:00:00
astellas pharma us
Pharmaceutical company
0
lobbying_income
service_provided
[ "General health care issues, issues related to FDA, pharmaceuticals" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q1
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "KENNETH LEE HODGE", "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)" ]
[ 139878, 42442, 51434, 60159 ]
[ null, null, null, "Legislative Director, Rep. Marsha Blackburn" ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/f51b3b1f-c7b9-42b4-ac63-82afa0a57f78/print/
f51b3b1f-c7b9-42b4-ac63-82afa0a57f78
f51b3b1f-c7b9-42b4-ac63-82afa0a57f78_46038_153900
astellas pharma us
2017-04-11T20:28:16
YNCHF
2017-04-18T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q1
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/417b9cfa-049c-4b3e-a1eb-aa9f805bd907/print/
417b9cfa-049c-4b3e-a1eb-aa9f805bd907
417b9cfa-049c-4b3e-a1eb-aa9f805bd907_305054_181397
astellas pharma us, inc.
2017-04-18T17:30:44
YNCHF
2017-04-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "issues relating to drug pricing, march-in rights under Bayh-Dole Act P.L. 96-517" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q1
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SEAN RICHARDSON" ]
[ 47178, 26450, 6542 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/122f5a63-9285-4a5d-ac3a-6ea4b93d5678/print/
122f5a63-9285-4a5d-ac3a-6ea4b93d5678
122f5a63-9285-4a5d-ac3a-6ea4b93d5678_20744_127151
astellas pharma us, inc.
2017-04-20T13:39:23
YNCHF
2017-04-20T00:00:00
astellas pharma us, inc.
null
820,000
a
service_provided
[ "Proposed Regulations under IRC Sec. 385 regarding their impact on the ability of U.S. subsidiaries to invest and grow in the United States and the competitiveness of the United States as a location for foreign direct investment; comprehensive tax reform.", "Issues related to oral chemotherapy in The Cancer Drug Coverage Parity Act of 2017 (H.R.1409); Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517); Issues related to the Prescription Drug User Fee Act (PDUFA) reauthorization; Issues related to importation (no specific bills).", "Issues related to the Medicare hospital outpatient issues; Medicare Part D policy issues." ]
[ "TAX - Taxation/Internal Revenue Code", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q1
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE" ]
[ 54800, 59772, 64567, 54800, 59772, 64567, 54800, 59772, 64567 ]
[ null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/eeaae2bb-581c-4f81-a0c6-14f81345645a/print/
eeaae2bb-581c-4f81-a0c6-14f81345645a
eeaae2bb-581c-4f81-a0c6-14f81345645a_40032268_188248
astellas pharma us, inc.
2017-04-20T17:56:30
YNCHF
2017-04-20T00:00:00
astellas pharma us, inc.
pharmaceutical company
50,000
lobbying_income
service_provided
[ "- Issues related to Medicare Part D", "- Issues involving the Federal, Food, Drug and Cosmetic Act (FFDCA), including reauthorization of the Prescription Drug User Fee Act (PDUFA VI)\n- Bayh-Dole Act/ march in authority\n- Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771)\n- Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)", "- Legislation repealing and replacing the Affordable Care Act, including the American Health Care Act (H.R. 1628)" ]
[ "MMM - Medicare/Medicaid", "PHA - Pharmacy", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q1
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY" ]
[ 64580, 56477, 56477, 64580, 64580, 56477 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/47263323-5f1f-44fa-a22f-7a73bf8fecb9/print/
47263323-5f1f-44fa-a22f-7a73bf8fecb9
47263323-5f1f-44fa-a22f-7a73bf8fecb9_400762305_195037
astellas pharma us, inc.
2017-04-20T20:41:42
YNCHF
2017-07-03T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "Issues related to drug importation, pharmaceutical pricing, and NIH March in Rights." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "18 - Office of Management & Budget (OMB)", "1 - SENATE" ]
2017-Q2
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)" ]
[ 42442, 51434, 60159, 53650 ]
[ null, null, "Legislative Director, Rep. Marsha Blackburn", "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President" ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/7edcabee-5c22-4ad2-a6d1-0112bf6666a4/print/
7edcabee-5c22-4ad2-a6d1-0112bf6666a4
7edcabee-5c22-4ad2-a6d1-0112bf6666a4_46038_153900
astellas pharma us
2017-07-03T16:11:18
YNCHF
2017-07-18T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing; H.R. 2430, FDA Re-authorization Act of 2017." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q2
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/1cd7290c-acb6-4e47-bee3-d712c504104f/print/
1cd7290c-acb6-4e47-bee3-d712c504104f
1cd7290c-acb6-4e47-bee3-d712c504104f_305054_181397
astellas pharma us, inc.
2017-07-18T20:28:24
YNCHF
2017-07-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "issues relating to drug pricing, march-in rights under Bayh-Dole Act P.L. 96-517 and transparency." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q2
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SEAN RICHARDSON" ]
[ 47178, 26450, 6542 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/14c23809-4ef2-4f6c-b757-cf10ad8f9cc8/print/
14c23809-4ef2-4f6c-b757-cf10ad8f9cc8
14c23809-4ef2-4f6c-b757-cf10ad8f9cc8_20744_127151
astellas pharma us, inc.
2017-07-20T13:14:56
YNCHF
2017-07-20T00:00:00
astellas pharma us, inc.
pharmaceutical company
50,000
lobbying_income
service_provided
[ "- FDA Reauthorization Act (H.R. 2430/S. 934)\n- Issues related to the Bayh-Dole Act (Pub. L. 96-517)\n- Issues related to drug pricing, including the Improving Access to Affordable Prescription Drug Act (S. 771)\n- Issues related to the importation of prescription medicines, including the Affordable and Safe Prescription Drug Importation Act (H.R. 1245/S. 469)", "- Issues related to Medicare Part B (HOPPS) and Part D" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q2
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY" ]
[ 64580, 56477, 64580, 56477 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/5df30990-6c7e-4d56-beaa-64136b6c0b39/print/
5df30990-6c7e-4d56-beaa-64136b6c0b39
5df30990-6c7e-4d56-beaa-64136b6c0b39_400762305_195037
astellas pharma us, inc.
2017-07-20T17:35:04
YNCHF
2017-07-20T00:00:00
astellas pharma us, inc.
null
0
a
service_provided
[ "Proposed Regulations under IRC Sec. 385 regarding their impact on the ability of U.S. subsidiaries to invest and grow in the United States and the competitiveness of the United States as a location for foreign direct investment; comprehensive tax reform.", "Issues related to oral chemotherapy in The Cancer Drug Coverage Parity Act of 2017 (H.R.1409); Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517); Issues related to the Prescription Drug User Fee Act (PDUFA) reauthorization; Issues related to importation (no specific bills).", "Issues related to the Medicare hospital outpatient issues; Medicare Part D policy issues.\nS. 251: Protecting Medicare from Executive Action Act of 2017 - Provisions related to repeal of the Independent Payment Advisory Board (IPAB)\nS. 260: Protecting Seniors' Access to Medicare Act of 2017 - Provisions related to repeal of the IPAB\nH.R. 849: Protecting Seniors' Access to Medicare Act of 2017 - Provisions related to repeal of the IPAB\nH.J.Res. 51 - Approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act - Provisions related to the IPAB repeal\nS.J.Res. 16 - A joint resolution approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act - Provisions related to the IPAB repeal" ]
[ "TAX - Taxation/Internal Revenue Code", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q2
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE" ]
[ 54800, 59772, 64567, 54800, 59772, 64567, 54800, 59772, 64567 ]
[ null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/d7eb07f6-8f0c-4d6f-9fce-1a367d6a69da/print/
d7eb07f6-8f0c-4d6f-9fce-1a367d6a69da
d7eb07f6-8f0c-4d6f-9fce-1a367d6a69da_40032268_188248
astellas pharma us, inc.
2017-07-20T18:34:53
YNCHF
2017-10-13T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "Drug importation, pharmaceutical pricing, NIH March In Rights, S.1519 - National Defense Authorization Act for Fiscal Year 2018.", "Corporate Tax Reform" ]
[ "HCR - Health Issues", "TAX - Taxation/Internal Revenue Code" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q3
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)" ]
[ 42442, 51434, 60159, 53650, 42442, 51434, 53650, 60159 ]
[ null, null, "Legislative Director, Rep. Marsha Blackburn", "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", null, null, "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", "Legislative Director, Rep. Marsha Blackburn" ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/6c276804-034e-4b40-81b4-824473e554db/print/
6c276804-034e-4b40-81b4-824473e554db
6c276804-034e-4b40-81b4-824473e554db_46038_153900
astellas pharma us
2017-10-13T14:17:25
YNCHF
2017-10-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "issues relating to drug pricing, march-in rights under Bayh-Dole Act P.L. 96-517 and transparency. S.1519, the National Defense Authorization Act for 2018, Section 892, Rights in technical data related to medical research. HR 2819 - National Defense Authorization Act (FY18), Amendment 342, Rep. Doggett" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q3
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SEAN RICHARDSON" ]
[ 47178, 26450, 6542 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/80df2509-3047-4817-9190-236257356265/print/
80df2509-3047-4817-9190-236257356265
80df2509-3047-4817-9190-236257356265_20744_127151
astellas pharma us, inc.
2017-10-20T13:14:42
YNCHF
2017-10-20T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing; S. 1519 and H.R. 2810, National Defense Authorization Act; Labor, HHS and Education FY18 Appropriations Bill" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q3
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/734b2a42-da45-4d59-8c63-b30b4778df95/print/
734b2a42-da45-4d59-8c63-b30b4778df95
734b2a42-da45-4d59-8c63-b30b4778df95_305054_181397
astellas pharma us, inc.
2017-10-20T13:46:53
YNCHF
2017-10-20T00:00:00
astellas pharma us, inc.
null
600,000
a
service_provided
[ "Issues related to oral chemotherapy in The Cancer Drug Coverage Parity Act of 2017 (H.R.1409); Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517); Issues related to the Prescription Drug User Fee Act (PDUFA) reauthorization; Issues related to importation (no specific bills).", "Proposed Regulations under IRC Sec. 385 regarding their impact on the ability of U.S. subsidiaries to invest and grow in the United States and the competitiveness of the United States as a location for foreign direct investment; comprehensive tax reform.", "Issues related to the Medicare hospital outpatient issues; Medicare Part D policy issues.\nS. 251: Protecting Medicare from Executive Action Act of 2017 - Provisions related to repeal of the Independent Payment Advisory Board (IPAB)\nS. 260: Protecting Seniors' Access to Medicare Act of 2017 - Provisions related to repeal of the IPAB\nH.R. 849: Protecting Seniors' Access to Medicare Act of 2017 - Provisions related to repeal of the IPAB\nH.J.Res. 51 - Approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act - Provisions related to the IPAB repeal\nS.J.Res. 16 - A joint resolution approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act - Provisions related to the IPAB repeal" ]
[ "HCR - Health Issues", "TAX - Taxation/Internal Revenue Code", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q3
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "SARAH CHRISTINE D'ORSIE", "MARY LACEY REUTHER", "SARAH CHRISTINE D'ORSIE", "MARY LACEY REUTHER", "SARAH CHRISTINE D'ORSIE" ]
[ 54800, 64567, 54800, 64567, 54800, 64567 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/bbf796b7-af87-437e-84f2-97301d7199b6/print/
bbf796b7-af87-437e-84f2-97301d7199b6
bbf796b7-af87-437e-84f2-97301d7199b6_40032268_188248
astellas pharma us, inc.
2017-10-20T17:41:33